Clinical Trial Update: BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery. [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial comparing nesiritide (BNP) to placebo to protect kidney function in patients undergoing heart bypass surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Nesiritide (Natrecor) (nesiritide)

Snippet

Sponsor: Mayo Clinic | Conditions: Acute Kidney Failure | Phase 1, Phase 2 | Status: COMPLETED